NOXXON announces a capital increase of Euro 1 million through a private placement of shares without warrants
(WorldNews Netherlands)

NOXXON ANNOUNCES A CAPITAL INCREASE OF EUR1 MILLION THROUGH A PRIVATE PLACEMENT OF SHARES WITHOUT WARRANTS Berlin, Germany, August 6, 2019, 08.00 p.m. CEST - NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today that following discussions with investors it has received letters of intent and binding commitments for long-terminvestment of EUR1 million through a private placement plus additional commitment for a future private placement. The price agreed with investors is EUR0.51 per share, representing a 10% discount on the average closing price of the shares over the seven...